Member Info for jdt1990

We're literally back at the price prior to the George street investment announcement. The vaccine news took the wind out of Vela's sales a little bit along with all other Covid stocks. News coming out daily about concerns over the vaccine news (which we knew would happen, the timing of all that was purely political and economically driven). Some good results from the trial will give this a boost.
Remember, the placing for half of the George street investment (>10% mktcap) was at 0.065 so with that will always come a dip as those additional shares clear.

MM's letting their insti mates in at bargain prices before the avalanche of newsflow comes in....

Looks like a lot of vaccine criticism continuing to play out (as expected), AZ/Oxford data now coming under fire. Bodes well for length of testing requirements.
Shame the SP hasn't jumped in the same way it tanked when vaccine news first hit.....but hey ho I have a funny feeling AS will come up with something very good here and silence his critics.

If they've got more high six figure orders on the book from instis, no wonder they are keeping a lit on it to fill them. I owuld think we'll see a few more of those....

It's been 4 weeks since we were told Vela have invested £2.35m in the COvid diabetes trial. That investment was 25% of the companies Mkt Cap and they had to raise half that via a placing at 0.065....a lot of shares came to market end Oct
Vaccine news has also not helped with the sentiment behind the Covid diabetes trial (despite a lot of vaccine related impact on the market being overdone).
How has communication and progress has really been dire? Do you want daily update RNS's and weekly investments?
Come on guys, this had drifted down to placing price on a quiet 4 week period - it was to be expected....

Sadly Bella you’ll have to try hammer that message home to the people peppering ASs inbox with are we there yet emails! I fully agree if a jobs worth doing it’s worth doing properly. There is also the reputation and integrity of a business that was doing great things before COViD to uphold. Avct is in a different league to some of the other COViD plays, who have done well don’t get me wrong but had a lot less to lose.
A lot of the unhappy “I want my 500% return in a day crew” will soon change their tune when this all falls into place.
And if I hear another thing about the bloody house....god forbid!

Lithium will eventually be replaced by Vanadium in the battery world anyway as VRFB's gather momentum

Good to know RightOn. So if we assign no additional value to the current mkt cap from these projects, but add the £5.7m from warrant sales and up the shares in issue. That gives you a a mkt cap of £25.84m with 467.1m in issue, equating to a "theoretical mkt value" SP of 5.5p and dilutive effect of ~30%.
However, its hard to think those will all exercise in one go. I think the Mkt cap upside here from EP being issued and first gold pour would very easily negate the dilutive impact of those warrants.

33,800 oz of gold just in the south pit. Lets say gold at ($1800 - $950 AISC)*120,700 / 1.3 = £79m pre tax.....triple current mkt cap. Upside here even with warrants is significant

VELA invested in the MODE IPO, so the business not bitcoin directly. The upside for Vela is not in the bitcoin price rise directly but the uptake from your Average Joe wanting exposure/access to bitcoin as it becomes either a bigger speculative investment OR digital currencies become more widely adopted. Nothing to say that wont happen with govts/central banks having to print money to cover the costs of Covid. The value of the USD will have to take a hit at some point.

Very true - surprises are never taken well. We all saw what happened over at SKIN when Gerry had hyped up the breath test (like an inhaler) then in the demo rolled out a whopping great machine to analyse it....the arse fell out of the SP and never recovered!

I agree there infinity, I genuinely believe AS has this business because he wants to make a difference in the world and loves the science. He's not an out and out businessman and has clearly been poorly advised on some business decisions which PIs are taking him to town on (and wrongly in my personal view).
Wyndrum come on, to do what AVCT are doing needs funding - its the pharma industry so he had to go public really to be able to progress it. Who knows he may just be waitting for a buyout where he can bin the CEO role and go back to doing the science full time not having to answer emails from whiney PI's who need their a** wiping every 3 seconds.

Okehurst - I really do hope the shorters TW and his merry crew get wiped out with this one. Limited upside and theoretically unlimited downside in the shorting game.....a string of good news and they could be burning with a lot of quick buys to close.

Well lets look at AgentB's comments in a positive way.....if Affimer is in there as an "approved structure", they know about it and it if we do tender we have a shot. If it wasn't in there, everyone would be saying "it can't be us".
So either way, its a step in the right direction

Affimer is a trademarked product by AVCT. So if anyone else uses Affimers they are supplied by AVCT.
So either someone else has a LFT that we are supplying Affimers for (that could only be a tie up with Mologic really) or the govt are very aware that we will be putting something forward for this tender. My thought is the latter.

Interesting to see in the doc that on P4 A typical kit contains (saliva is still there so it isn't a complete gonner that just confirms what we thought yesterday in that AVCT have switched to swab to be part of this 25th Nov tender as that is clearly govt perfrence):
• Cassette
• Sterile swab (depending on use) or
• Saliva collection vessel, possibly with funnel (for saliva samples)
• Antigen Extraction tube
• Extraction reagent/buffer
• IFU (Instructions for Use)

I've been trying to find some info on speed of RAB drilling. The only company that quoted speed to drill was Ground Truth who state:
"Our ultra-portable GT RAB Drill is capable of reaching depths of up to 100m in a 12 hour drilling shift."
Now looking at Amazon Drilling Limited's website (they do exist which is a good start) their fleet seems to be a lot more industrial than this portable drill.
So we know they are going to drill 50 x 40m holes initially. Lets say worst case they can do three of those in a day shift (assuming 1 rig as their fleet on the website isn't huge). That's 16 working days / 3 weeks there or there abouts to complete the maiden RAB drilling programme.
Not sure when they will start drilling but assuming no Covid related delays along the way, I think we are looking at an update on the maiden drill programme in the run up to Christmas. You would think each holes results could be analysed in tandem with the drilling so its not like we will have to wait for all drilling to finish for results to be analysed.

Disclaimer: Joyous, please forgive me for researching something not in an RNS, posting that on the BB and "speculating". This in my opinion and you don't have read it or use it....I know you only operate on RNS info.

Pigster I am of the opinion this change of focus from saliva to swab has been purely driven by the govt who want a uniform sample collection method across the tests in their programme.
To get their contracts it’s not about having a unique method - that’s too much effort for them to try and validate/assess. It’s about a test that performs above the required standards and the other tests in the market.
Affimers are the USP and I can’t see innovas S&S being hard to beat. I’m just glad AS chose to make the move (albeit maybe this should have been the option from the get go but hindsight is great) and didn’t just bundle along with a saliva lft that may or may not get off the ground.
This move is clearly to get govt orders and being swab are their terms

Fekir - Not sure what your issue with the remuneration piece is? Simply a change of vesting period for the equity component:
Shareholder value has been eroded by a drop in vanadium prices, something the directors cannot control. I would say they are delivering the business strategy appropriately if not brilliantly under the current circumstances. Production up and costs down - that’s how we want it to negate the impact of lower Vanadium prices that are not in the control of BMN....
“Following the implementation of the Company's incentive schemes in 2019, their effectiveness has been reviewed and the Remuneration Committee ("RemCo") considered changes to the short-term incentive scheme ("STI") construct to reward performance that supports the delivery of the business strategy appropriately. It was found that the deferred equity component of the STI was mirroring the long-term incentive scheme structure, which was considered too onerous for an STI. Consequently, RemCo has approved a revised vesting period so that 50 per cent of the shares vest 12 months after the end of the award period and 50 per cent 18 months after the end of the award period. This amendment will be applied retrospectively to the 2019 STI Bonus Awards announced by the Company on 20 July 2020.”

Tracker funds also don’t have to replicate the constituents of the index 100%. They just have to invest broadly in line to ensure their return “tracks” the return of the index. So let’s say GGP is 0.5% of the index, that doesn’t necessarily mean 0.5% of all AUM in msci small cap trackes will go into GGP.
The answer is that it’s pretty much impossible to calculate how much buying will happen off the back of this. It’s not like GDXJ where you can reverse engineer it pretty well.

I see Skipton building society are doing 0.6% instant access ISA....probably worth a few people taking that up. No paper losses to cry about there and no RNS's required. It will also save us all having to listen to the "are we there yet".
As for the derampers, green box of graveyards today which usually suggests there's something positive worth trying to drown out with "AS sold some shares" "it was supposed to be here in summer" "we've been duped as they've abandoned the saliva test"
Dec is looking good...